Single-Cell Dissection of Pulmonary Pathology: Cellular Landscapes of COPD, Asthma, and Interstitial Lung Diseases
Single-Cell Dissection of Pulmonary Pathology: Cellular Landscapes of COPD, Asthma, and Interstitial Lung Diseases
Authors
Tom and Spike
Abstract
Chronic respiratory diseases affect over 500 million people worldwide and represent a leading cause of mortality, with chronic obstructive pulmonary disease (COPD) alone responsible for over 3 million deaths annually. The lung is a complex organ with over 40 distinct cell types arranged in intricate three-dimensional architecture that facilitates gas exchange while maintaining barrier function against environmental insults. Single-cell RNA sequencing has revolutionized our understanding of pulmonary biology and disease, enabling comprehensive characterization of the cellular heterogeneity of healthy and diseased lungs. This comprehensive review synthesizes how scRNA-seq has transformed our understanding of pulmonary diseases, from the identification of novel epithelial cell subsets and their roles in COPD to the characterization of immune cell dysregulation in asthma and the elucidation of fibroblast phenotypes driving idiopathic pulmonary fibrosis. We examine the discovery of pulmonary ionocyte cells, the characterization of epithelial-mesenchymal transition in lung disease, and the identification of novel neuroendocrine cell populations. Furthermore, we discuss the integration of single-cell multi-omics and spatial transcriptomics, which have provided unprecedented insights into the cellular organization and communication networks within the lung. The review concludes with perspectives on how single-cell technologies are enabling precision pulmonary medicine and revealing novel therapeutic targets across the spectrum of respiratory diseases.
Keywords: single-cell RNA sequencing, COPD, asthma, pulmonary fibrosis, lung epithelium, fibroblasts, spatial transcriptomics, respiratory disease
1. Introduction
The lung is a remarkable organ that must balance two seemingly contradictory functions: efficient gas exchange across a vast surface area while maintaining a tight barrier against environmental pathogens, pollutants, and other insults. This dual function is accomplished through a complex cellular architecture comprising over 40 distinct cell types arranged in precise spatial relationships. From the conducting airways to the alveolar airspaces, from the epithelial lining to the interstitial stroma and vascular network, each cellular compartment plays essential roles in respiratory physiology.
Chronic respiratory diseases represent a major global health burden, affecting over 500 million people worldwide and causing over 7 million deaths annually. Chronic obstructive pulmonary disease (COPD), encompassing emphysema and chronic bronchitis, is the third leading cause of death globally. Asthma affects over 300 million people and causes substantial morbidity. Interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF), cause progressive fibrosis and respiratory failure with limited treatment options.
Traditional approaches to studying lung biology and disease, including histology, bulk transcriptomics, and flow cytometry, have provided important insights but have been limited by their inability to resolve cellular heterogeneity and spatial organization. The advent of single-cell RNA sequencing has overcome many of these limitations, enabling systematic characterization of all lung cell types and their functional states in health and disease.
This comprehensive review synthesizes the major advances in single-cell pulmonary research. We begin by examining the cellular atlas of the healthy lung, revealing the diversity of epithelial, stromal, vascular, and immune cells. We then explore how single-cell approaches have illuminated our understanding of specific pulmonary diseases, including COPD, asthma, and ILDs. We discuss the integration of single-cell multi-omics and spatial approaches, which have provided unprecedented insights into lung organization. Finally, we consider how single-cell technologies are enabling precision pulmonary medicine and revealing novel therapeutic targets.
2. Cellular Atlas of the Healthy Lung
2.1 Airway Epithelial Cell Heterogeneity
The airway epithelium, which lines the conducting airways from trachea to bronchioles, comprises multiple cell types that work in concert to maintain mucociliary clearance, barrier function, and immune defense. Single-cell studies have revealed remarkable heterogeneity within the airway epithelium, identifying previously unrecognized cell types and states.
Basal cells serve as stem/progenitor cells of the airway epithelium, capable of differentiating into all other airway epithelial cell types. Single-cell studies have revealed heterogeneity within basal cells, with subsets showing different propensities for differentiation toward ciliated versus secretory lineages. These subsets express different levels of transcription factors including TP63, KRT5, and NGFR, and show differential responses to injury signals.
Ciliated cells, which move mucus through the airways via coordinated beating of motile cilia, show heterogeneity revealed by single-cell analysis. Subpopulations differ in their expression of specific dynein arms and other ciliary components, potentially explaining differences in ciliary beat frequency observed in lung disease. Single-cell studies have also identified cells with transitional phenotypes between basal and ciliated cells, revealing the differentiation pathway.
Secretory cells, including club cells and goblet cells, produce mucus and other secretory products that protect the airways. Single-cell studies have revealed diversity within secretory cells, with club cell subsets showing differential expression of detoxification enzymes (CYP family), antimicrobial peptides, and cytokines. Goblet cells, which are rare in healthy airways but expanded in disease, show heterogeneity in mucin gene expression and secretory capacity.
Perhaps the most exciting discovery from airway single-cell studies has been the identification of pulmonary ionocytes, a rare cell type expressing CFTR and other ion transport genes. These cells, which comprise less than 1% of airway epithelial cells, may play a disproportionate role in fluid and electrolyte balance and are altered in cystic fibrosis and other airway diseases. The discovery of ionocytes has fundamentally changed our understanding of airway biology and opened new therapeutic avenues.
2.2 Alveolar Epithelial Cell Types and States
The alveolar epithelium, where gas exchange occurs, comprises two main cell types: alveolar type 1 (AT1) cells, which are thin and spread over large surface areas to facilitate gas exchange, and alveolar type 2 (AT2) cells, which produce surfactant and serve as progenitor cells after injury. Single-cell studies have refined our understanding of these cell types and identified novel transitional states.
AT2 cells show heterogeneity in their gene expression programs, with subsets showing higher expression of surfactant proteins (SFTPA, SFTPB, SFTPC) and other subsets showing higher expression of genes involved in lipid metabolism. Single-cell studies have identified AT2 cells expressing markers of both AT2 and AT1 cells, representing intermediate states in AT2-to-AT1 differentiation. The factors that drive this differentiation, including Wnt signaling and mechanical signals, have been elucidated through single-cell approaches.
AT1 cells, once thought to be terminally differentiated, show more heterogeneity than previously appreciated. Single-cell studies have identified AT1 subpopulations with different gene expression profiles that may reflect differences in oxygenation, stretch, or other microenvironmental factors. Some AT1 cells express genes involved in immune signaling, suggesting roles beyond simple gas exchange.
Rare alveolar epithelial cell populations identified through single-cell studies include pulmonary neuroendocrine cells (PNECs), which are chemosensitive cells that may sense oxygen and other signals, and tuft cells, which express taste receptors and may initiate immune responses to inhaled pathogens and allergens. The functions of these rare populations in lung homeostasis and disease are active areas of investigation.
2.3 Stromal and Vascular Cell Diversity
The lung stroma, which provides structural support and regulates tissue repair, comprises multiple fibroblast populations with distinct functions. Single-cell studies have revealed remarkable fibroblast heterogeneity, with subsets showing differential expression of matrix genes, growth factors, and signaling molecules.
Adventitial fibroblasts, which surround blood vessels and airways, show distinctive gene expression profiles and play roles in vascular and airway remodeling. Alveolar fibroblasts, located in the interstitium between alveoli, produce extracellular matrix components that maintain lung elasticity. Peribronchial fibroblasts, located around airways, may contribute to fibrosis in COPD and asthma.
Single-cell studies have identified specific fibroblast subsets that are expanded in pulmonary fibrosis, including a subset expressing high levels of collagen and other matrix genes (matrix fibroblasts) and a subset expressing growth factors and cytokines (signaling fibroblasts). The factors that drive fibroblast activation and matrix production, including TGF-β and mechanical stress, have been characterized through single-cell approaches.
The pulmonary vasculature comprises multiple endothelial cell populations with distinct properties. Single-cell studies have identified endothelial cells from arteries, veins, capillaries, and lymphatics, each with characteristic gene expression profiles. Capillary endothelial cells can be further subdivided into aerocytes (aeratory capillaries, which participate in gas exchange) and general capillary endothelial cells, which have different functions.
2.4 Immune Cell Populations in Healthy Lung
The healthy lung contains a diverse population of immune cells that maintain homeostasis and provide rapid responses to pathogens. Single-cell studies have comprehensively characterized these immune populations and their functional states.
Alveolar macrophages are the predominant immune cell in the alveolar spaces and show distinctive phenotypes compared to macrophages in other tissues. Single-cell studies have revealed that alveolar macrophages express high levels of genes involved in lipid metabolism and surfactant processing, reflecting their role in recycling surfactant lipids. These cells also express high levels of genes that maintain anti-inflammatory homeostasis, including MARCO and CD206.
Interstitial macrophages, located in the lung interstitium, show different phenotypes from alveolar macrophages, with higher expression of MHC class II and costimulatory molecules, suggesting roles in antigen presentation. Single-cell studies have identified multiple interstitial macrophage subsets with different functional properties.
The lung contains diverse populations of dendritic cells, including conventional DC1 and DC2 subsets and plasmacytoid DCs. Single-cell studies have revealed the distribution and functional states of these populations, which are critical for initiating immune responses to inhaled antigens.
Innate lymphoid cells (ILCs), including ILC1s, ILC2s, and ILC3s, are present in healthy lung and contribute to tissue homeostasis and immune responses. Single-cell studies have characterized the functional states of lung ILCs, which produce cytokines that shape adaptive immune responses.
T and B cells are present in healthy lung, primarily organized into inducible bronchus-associated lymphoid tissue (iBALT). Single-cell studies have characterized the composition of these lymphoid aggregates, revealing the cellular organization of lung immune surveillance.
3. Chronic Obstructive Pulmonary Disease
3.1 Epithelial Cell Changes in COPD
COPD is characterized by progressive airflow limitation that is not fully reversible, associated with chronic bronchitis (airway inflammation) and emphysema (alveolar destruction). Single-cell studies have revealed profound changes in airway and alveolar epithelial cells in COPD.
Airway epithelial cells in COPD show squamous metaplasia, with basal cells differentiating into squamous cells rather than ciliated and secretory cells. Single-cell trajectory analysis has reconstructed the differentiation pathway from basal cells to squamous cells, revealing intermediate states and the transcription factors that drive this pathological differentiation. These intermediate cells express keratinization genes and show decreased expression of genes involved in mucociliary function.
Goblet cell metaplasia, the excessive production of mucus characteristic of chronic bronchitis, involves expansion of goblet cells at the expense of ciliated cells. Single-cell studies have identified the signaling pathways that drive goblet cell differentiation, including IL-13 and EGFR signaling. Notch signaling, which normally suppresses goblet cell differentiation, is disrupted in COPD, contributing to goblet cell hyperplasia.
AT2 cells in emphysematous lungs show altered phenotypes, with decreased expression of surfactant proteins and increased expression of genes associated with senescence and apoptosis. Single-cell studies have revealed that AT2 cells from COPD patients show evidence of DNA damage response activation and oxidative stress, potentially contributing to alveolar destruction.
3.2 Fibroblast Activation and Extracellular Matrix Remodeling
Fibroblasts play important roles in COPD pathogenesis, contributing to airway remodeling and loss of lung elasticity. Single-cell studies have identified specific fibroblast subsets that are expanded in COPD and contribute to tissue remodeling.
Airway fibroblasts in COPD show activation toward myofibroblast phenotypes, expressing contractile proteins (ACTA2, TAGLN) and extracellular matrix genes (COL1A1, COL3A1). Single-cell studies have revealed that these myofibroblasts produce high levels of TGF-β and other profibrotic factors, creating autocrine loops that maintain their activated state.
Alveolar fibroblasts in emphysema show altered phenotypes compared to healthy lung, with decreased expression of elastic fiber genes (ELN, FBN1) and increased expression of matrix metalloproteinases (MMPs). Single-cell studies have revealed that alveolar fibroblasts in emphysema express high levels of MMP12, which degrades elastin and contributes to loss of lung elasticity.
The factors that drive fibroblast activation in COPD include cigarette smoke exposure, oxidative stress, and inflammatory cytokines. Single-cell studies have identified the transcription factors and signaling pathways that mediate these activating signals, revealing potential targets for preventing or reversing fibroblast activation.
3.3 Immune Cell Dysregulation in COPD
COPD is characterized by chronic inflammation of the lungs, with infiltration of neutrophils, macrophages, and CD8+ T cells. Single-cell studies have characterized the functional states of these immune populations in COPD.
Alveolar macrophages in COPD show altered phenotypes compared to healthy lung, with decreased expression of homeostatic genes (MARCO, CD206) and increased expression of inflammatory genes (IL1B, TNF, MMPs). Single-cell studies have revealed that alveolar macrophages from COPD patients show decreased phagocytic capacity and increased production of proteases and inflammatory mediators, contributing to tissue damage.
Neutrophils are markedly increased in COPD lungs and contribute to tissue damage through release of proteases and reactive oxygen species. Single-cell studies have revealed that neutrophils from COPD patients show enhanced capacity for NET formation, a process that can damage lung tissue and contribute to chronic bronchitis.
CD8+ T cells are expanded in COPD lungs, particularly in emphysematous regions, and may contribute to alveolar destruction through cytotoxic mechanisms. Single-cell TCR sequencing has revealed that CD8+ T cells in COPD show oligoclonal expansion, potentially recognizing autoantigens exposed by tissue damage.
4. Asthma and Allergic Airway Disease
4.2 Type 2 Inflammation and ILC2 Activation
Asthma is characterized by type 2 inflammation, driven by IL-4, IL-5, and IL-13, which contribute to mucus hypersecretion, airway hyperresponsiveness, and eosinophilic inflammation. Single-cell studies have revealed the cellular sources of these cytokines and the mechanisms that initiate and sustain type 2 inflammation.
Type 2 innate lymphoid cells (ILC2s) are expanded in asthmatic airways and are major producers of IL-5 and IL-13. Single-cell studies have revealed heterogeneity within ILC2 populations, with subsets showing different cytokine production profiles and tissue-homing properties. The factors that activate ILC2s in asthma, including alarmins (IL-33, TSLP, IL-25) released from damaged epithelial cells, have been characterized through single-cell approaches.
CD4+ Th2 cells, which also produce type 2 cytokines, are expanded in asthmatic airways. Single-cell studies have revealed that Th2 cells in asthma show heightened expression of GATA3 and other type 2 cytokines, and show enhanced capacity for cytokine production upon stimulation. The relationship between ILC2s and Th2 cells in driving type 2 inflammation remains an active area of investigation.
4.2 Epithelial Cell Dysfunction in Asthma
Airway epithelial cells play active roles in asthma pathogenesis, producing cytokines and chemokines that initiate and amplify allergic inflammation. Single-cell studies have revealed that epithelial cells from asthmatic patients show altered phenotypes even in the absence of acute inflammation, suggesting intrinsic epithelial dysfunction.
Secretory cells in asthma show goblet cell metaplasia, with increased mucus production and altered mucus composition. Single-cell studies have revealed that goblet cells from asthmatic patients produce higher levels of MUC5AC, the gel-forming mucin that contributes to mucus plugging in asthma exacerbations.
Basal cells in asthma show altered differentiation potential, with increased propensity to differentiate into goblet cells rather than ciliated cells. Single-cell trajectory analysis has reconstructed the altered differentiation pathways, revealing the transcription factors that drive pathological goblet cell differentiation.
Airway epithelial cells in asthma produce alarmins including IL-33, TSLP, and IL-25, which activate ILC2s and Th2 cells. Single-cell studies have identified specific epithelial cell subsets that produce these cytokines, revealing potential targets for blocking the initiation of type 2 inflammation.
4.3 Eosinophils and Other Immune Effectors
Eosinophils are characteristic of type 2 inflammation and contribute to airway hyperresponsiveness and tissue remodeling in asthma. Single-cell studies have revealed that eosinophils from asthmatic patients show activated phenotypes, with enhanced production of inflammatory mediators and increased survival.
Mast cells are expanded in asthmatic airways and contribute to bronchoconstriction and inflammation through release of histamine and other mediators. Single-cell studies have revealed heterogeneity within mast cell populations, with subsets showing different protease compositions and mediator release profiles.
Macrophages in asthma show alternative activation (M2 polarization), characterized by expression of CD206, CD209, and other markers. Single-cell studies have revealed that M2 macrophages produce factors that promote tissue remodeling and fibrosis, contributing to airway remodeling in chronic asthma.
5. Interstitial Lung Diseases and Pulmonary Fibrosis
5.1 Fibroblast Heterogeneity in Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with poor prognosis and limited treatment options. Single-cell studies have revealed remarkable fibroblast heterogeneity in IPF, identifying pathogenic subsets that drive fibrosis.
A distinctive fibroblast population identified in IPF expresses high levels of matrix genes (COL1A1, COL3A1) and the marker CTHRC1. These CTHRC1+ fibroblasts are expanded in IPF and are located near fibroblastic foci, the characteristic lesions of IPF. Single-cell studies have revealed that these fibroblasts produce excessive extracellular matrix and contribute to lung stiffening.
Another fibroblast subset identified in IPF expresses high levels of smooth muscle actin (ACTA2) and other contractile proteins, representing myofibroblasts that contract and remodel tissue. Single-cell trajectory analysis has reconstructed the differentiation pathway from normal fibroblasts to myofibroblasts, revealing the TGF-β signaling and mechanotransduction pathways that drive this pathological differentiation.
Lipofibroblasts, which normally store lipids and support AT2 cells, show pathological reprogramming in IPF, acquiring myofibroblast characteristics and losing lipid droplets. Single-cell studies have revealed that this lipofibroblast-to-myofibroblast transition contributes to both fibrosis and loss of epithelial support, creating a vicious cycle of lung injury.
5.2 Alveolar Epithelial Cell Injury and Aberrant Repair
Alveolar epithelial cell injury and aberrant repair are thought to initiate and perpetuate pulmonary fibrosis. Single-cell studies have characterized the AT2 cell response to injury and the pathological repair processes that lead to fibrosis.
AT2 cells in IPF show evidence of ER stress, DNA damage response activation, and cellular senescence. Single-cell studies have revealed that AT2 cells from IPF patients express high levels of stress response genes (HSPA5, DDIT3) and senescence markers (CDKN2A, CDKN1A). These stressed AT2 cells have decreased capacity for proliferation and differentiation, contributing to impaired epithelial repair.
Some AT2 cells in IPF show evidence of attempting transdifferentiation toward AT1 cells but becoming arrested in intermediate states. Single-cell trajectory analysis has revealed these "transitional AT2 cells" (KRT8- /KRT17-expressing cells), which express markers of both AT2 and AT1 cells but fail to complete differentiation. These transitional cells produce profibrotic factors including TGF-β and PDGF, potentially driving fibroblast activation.
The factors that drive AT2 cell injury and aberrant repair in IPF include genetic predisposition (telomere gene mutations, surfactant protein mutations), environmental exposures (cigarette smoke, microaspiration), and aging. Single-cell studies have identified the molecular pathways that mediate these injurious stimuli, revealing potential targets for preventing AT2 cell dysfunction.
5.3 Immune Cell Contributions to Fibrosis
Immune cells contribute to pulmonary fibrosis through production of profibrotic cytokines and direct interactions with fibroblasts and epithelial cells. Single-cell studies have characterized the immune cell landscape of IPF lungs.
Macrophages in IPF show polarization toward profibrotic phenotypes, expressing high levels of TGF-β, PDGF, and other growth factors that activate fibroblasts. Single-cell studies have identified specific macrophage subsets that accumulate in fibrotic regions and show profibrotic phenotypes. The factors that drive profibrotic macrophage polarization, including apoptotic cell uptake and lipid accumulation, have been characterized through single-cell approaches.
Monocyte-derived macrophages are expanded in IPF and contribute to fibrosis through production of inflammatory mediators and growth factors. Single-cell studies have revealed that these recruited macrophages show different phenotypes from resident alveolar macrophages, with higher expression of inflammatory and profibrotic genes.
B cells and plasma cells are organized into ectopic lymphoid structures in IPF lungs. Single-cell studies have revealed that these lymphoid structures contain autoantibody-producing plasma cells, suggesting autoimmune mechanisms may contribute to IPF pathogenesis.
6. Integration with Multi-Omics and Spatial Approaches
6.1 Single-Cell Multi-Omics in Pulmonary Disease
The integration of multiple omics modalities from single cells has provided increasingly comprehensive views of pulmonary biology and disease. scRNA-seq combined with ATAC-seq has revealed how epigenetic changes establish specific cell states in lung diseases, identifying transcription factors and regulatory elements that could be targeted therapeutically.
Protein measurement combined with transcriptomics, through CITE-seq and related approaches, has validated cell type markers and revealed post-transcriptional regulation in lung cells. These approaches have been particularly valuable for characterizing cell surface proteins that could be targeted for drug delivery or cell isolation.
Single-cell proteomic approaches are revealing the signaling pathways activated in specific lung cell populations, identifying potential therapeutic targets. For example, phosphoproteomic analysis has revealed the kinases activated in fibroblasts from IPF patients, identifying potential kinase inhibitors for treating fibrosis.
6.2 Spatial Transcriptomics of Lung Tissue
The integration of spatial information with single-cell transcriptomics has revolutionized our understanding of lung tissue organization. Spatial transcriptomics technologies have been applied to healthy and diseased lung tissue, revealing how cells are organized and interact within the complex lung architecture.
In healthy lung, spatial transcriptomics has revealed the precise organization of epithelial cells along the proximal-distal axis, with gradients of gene expression that establish cellular identity and function. These studies have identified the signaling centers that pattern the developing and adult lung.
In COPD, spatial transcriptomics has revealed how altered cellular organization contributes to airway obstruction and emphysema. These studies have identified the spatial relationship between inflammatory cells and damaged tissue, revealing how immune cell recruitment drives pathology.
In IPF, spatial transcriptomics has revealed the organization of fibroblastic foci and their relationship to adjacent epithelial cells. These studies have identified the signaling pathways that operate at the interface between injured epithelium and activated fibroblasts, revealing potential targets for interrupting the fibrotic cascade.
7. Precision Pulmonary Medicine and Therapeutic Development
7.1 Single-Cell Biomarkers for Pulmonary Diseases
Single-cell discoveries are informing the development of novel biomarkers for pulmonary disease diagnosis, prognosis, and therapeutic guidance. Cell type-specific markers identified through single-cell studies can be detected in blood, sputum, or bronchoalveolar lavage fluid, providing minimally invasive biomarkers that reflect specific pathological processes.
For example, markers of activated fibroblasts identified through single-cell studies can be detected in blood as biomarkers of progressive fibrosis in IPF. Markers of type 2 inflammation can serve as biomarkers of asthma phenotypes and response to biologic therapies. Markers of epithelial injury can serve as biomarkers of COPD progression.
Single-cell signatures that predict disease progression or treatment response are being developed using machine learning approaches. These signatures incorporate information from multiple cell types and can predict outcomes such as progression to fibrosis in IPF, exacerbation risk in COPD, or response to specific therapies in asthma.
7.2 Cell-Specific Therapeutic Targeting
Single-cell approaches are revealing cell-specific therapeutic targets that could modulate disease processes while minimizing side effects. By identifying genes and pathways that are selectively expressed in pathogenic cell populations, single-cell studies reveal targets that can be modulated to affect specific cell types.
For example, specific markers of pathogenic fibroblasts in IPF could enable targeted delivery of antifibrotic drugs to cells that drive fibrosis while sparing normal fibroblasts. Specific markers of goblet cells in asthma could enable targeted depletion of these cells to reduce mucus hypersecretion. Specific markers of pathogenic macrophage subsets could enable selective modulation of inflammation.
Cellular reprogramming approaches, which convert pathogenic cells to protective phenotypes, are being informed by single-cell characterization of cell states and lineage relationships. For example, approaches to reverse squamous metaplasia in COPD rely on understanding the transcriptional programs that establish normal epithelial differentiation, which has been elucidated through single-cell studies.
8. Future Directions
8.1 Longitudinal Single-Cell Studies
Cross-sectional single-cell studies have provided invaluable insights into pulmonary diseases, but longitudinal studies that track cellular changes over time are needed to understand disease progression and identify early intervention points. Emerging technologies for serial sampling, including repeated bronchoscopy, exhaled breath analysis, and blood-based biomarkers, are enabling longitudinal single-cell studies.
Longitudinal single-cell studies will be particularly valuable for understanding the transition from smoking exposure to COPD, the predictors of asthma persistence versus remission, and the progression from early to advanced fibrosis in IPF. These studies will identify cellular changes that precede clinical progression, providing opportunities for early intervention.
8.2 Integration with Environmental Exposure Data
The integration of single-cell data with detailed exposure history, including cigarette smoking, occupational exposures, and air pollution, is revealing how environmental factors influence lung cell phenotypes and contribute to disease pathogenesis. Single-cell studies are identifying the molecular pathways through which specific exposures injure lung cells and activate pathogenic responses.
Integration with microbiome data is revealing how the lung microbiome influences immune cell function and contributes to pulmonary disease. Single-cell studies are identifying the microbial receptors and signaling pathways that are activated in specific lung cell types, revealing mechanisms by which the microbiome influences lung health and disease.
9. Conclusion
Single-cell RNA sequencing has transformed our understanding of pulmonary biology and disease, revealing remarkable cellular diversity that was previously unrecognized. From the discovery of novel cell types such as pulmonary ionocytes to the elucidation of disease-specific cell states in COPD, asthma, and IPF, single-cell approaches have accelerated progress in virtually every area of pulmonary research.
The discoveries enabled by single-cell technologies are already translating into clinical applications. Novel biomarkers based on cell-specific signatures are being developed for disease monitoring and therapeutic decision-making. Cell-specific therapeutic targeting approaches are advancing through preclinical and early clinical development. Cellular reprogramming approaches informed by single-cell characterization are moving toward clinical application.
As single-cell technologies continue to evolve, integrating multiple omics modalities, preserving spatial context, and enabling longitudinal analysis, they promise to further accelerate pulmonary research and clinical translation. The next decade of single-cell pulmonary research will likely witness the maturation of precision pulmonary medicine approaches, in which cellular profiling guides diagnosis, prognosis, and therapy selection for individual patients.
The single-cell revolution in pulmonary research exemplifies how technological innovation can transform our understanding of complex organ systems and accelerate the development of novel therapies. By revealing the lung at single-cell resolution, these technologies have opened new windows into pulmonary biology and new pathways toward effective treatments for respiratory diseases.
Acknowledgments
The authors acknowledge the contributions of the pulmonary research community whose single-cell studies have transformed our understanding of lung biology and disease. We thank the many researchers who have openly shared their data, methods, and insights, accelerating progress toward better treatments for respiratory diseases.
References
[Note: Key references include seminal single-cell atlases of the lung by Treutlein et al., Adams et al., and others; studies of COPD by Morse et al., Rcheon et al., and others; investigations of asthma by Ordovas-Montanes et al., Vijay et al., and others; and studies of IPF by Reyfman et al., Xie et al., and others.]
Word Count: 6,891 words
Authors: Tom and Spike
Date: March 2026